Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells - PubMed (original) (raw)
Affiliations
- PMID: 7723747
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells
J R Traynor et al. Mol Pharmacol. 1995 Apr.
Abstract
The ability of mu-opioid agonists to activate G proteins has been demonstrated by studying the binding of the GTP analogue guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTP gamma S) to membranes from the human neuroblastoma SH-SY5Y cell line. The potent opioid agonist fentanyl caused an approximate doubling of basal [35S]GTP gamma S binding in a naloxone-sensitive manner, confirming this to be an opioid receptor-mediated process. The presence of GDP was necessary to observe this effect. Pretreatment of the cells with pertussis toxin (100 ng/ml, for 24 hr) completely prevented the fentanyl-stimulated increase in [35S]GTP gamma S binding and lowered the basal binding of [35S]GTP gamma S. These latter data suggest an involvement of Gi and/or Go proteins and their activation by added membrane-bound receptors even in the absence of agonist. The order of potency of a series of opioid agonists in stimulating the binding of [35S]GTP gamma S was buprenorphine > cyclazocine = levallorphan > nalorphine > [D-Ala2,MePhe4,Gly-ol5]enkephalin (DAMGO) > fentanyl > morphine > pentazocine. DAMGO, fentanyl, and morphine were full agonists but the remaining compounds showed decreasing levels of intrinsic activity in the order buprenorphine > pentazocine > cyclazocine = nalorphine > levallorphan. The opioid antagonist naloxone was without effect. Under the conditions of the [35S]GTP gamma S assay, binding of agonists was to a high affinity site, indicating that a high agonist affinity state of the mu-opioid receptor is responsible for the observed stimulation of [35S]GTP gamma S binding. The level of [35S]GTP gamma S binding (597 fmol/mg of protein) stimulated by DAMGO was 2-fold greater than the maximal number of mu-opioid agonist binding sites (Bmax) determined using [3H]DAMGO (254 fmol/mg of protein). The opioid agonist-mediated stimulation of [35S]GTP gamma S binding in SH-SY5Y cell membranes thus provides a "functional" measure of agonist occupation of mu-opioid receptors and offers a simple method for the determination of efficacy and intrinsic activity of mu-opioid agonists.
Similar articles
- Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Emmerson PJ, et al. J Pharmacol Exp Ther. 1996 Sep;278(3):1121-7. J Pharmacol Exp Ther. 1996. PMID: 8819494 - [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].
Narita M. Narita M. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998 Aug;18(4):107-16. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998. PMID: 9866825 Review. Japanese. - Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding.
Bidlack JM, Parkhill AL. Bidlack JM, et al. Methods Mol Biol. 2004;237:135-43. doi: 10.1385/1-59259-430-1:135. Methods Mol Biol. 2004. PMID: 14501046 Review.
Cited by
- In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor.
Casal-Dominguez JJ, Clark M, Traynor JR, Husbands SM, Bailey SJ. Casal-Dominguez JJ, et al. J Psychopharmacol. 2013 Feb;27(2):192-202. doi: 10.1177/0269881112464828. Epub 2012 Oct 31. J Psychopharmacol. 2013. PMID: 23118019 Free PMC article. - Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans.
Ötvös F, Szűcs E, Urai Á, Köteles I, Szabó PT, Varga ZK, Gombos D, Hosztafi S, Benyhe S. Ötvös F, et al. Sci Rep. 2023 Nov 20;13(1):20305. doi: 10.1038/s41598-023-46317-3. Sci Rep. 2023. PMID: 37985681 Free PMC article. - Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.
Holden KG, Tidgewell K, Marquam A, Rothman RB, Navarro H, Prisinzano TE. Holden KG, et al. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6111-5. doi: 10.1016/j.bmcl.2007.09.050. Epub 2007 Sep 15. Bioorg Med Chem Lett. 2007. PMID: 17904842 Free PMC article. - Structure-Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics.
Montgomery D, Anand JP, Baber MA, Twarozynski JJ, Hartman JG, Delong LJ, Traynor JR, Mosberg HI. Montgomery D, et al. Molecules. 2019 Nov 26;24(23):4302. doi: 10.3390/molecules24234302. Molecules. 2019. PMID: 31779072 Free PMC article. - Development of tolerance and sensitization to different opioid agonists in rats.
Grecksch G, Bartzsch K, Widera A, Becker A, Höllt V, Koch T. Grecksch G, et al. Psychopharmacology (Berl). 2006 Jun;186(2):177-84. doi: 10.1007/s00213-006-0365-8. Epub 2006 Mar 30. Psychopharmacology (Berl). 2006. PMID: 16572262
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials